炎症性腸疾患体外診断の世界市場規模・現状・予測2021年-2027年

QYResearchが発行した調査報告書(QY21JNE2399)
◆英語タイトル:Global In-vitro Inflammatory Bowel Disease Diagnostic Market Size, Status and Forecast 2021-2027
◆商品コード:QY21JNE2399
◆発行会社(リサーチ会社):QYResearch
◆発行日:2021年6月(※2024年版があります。お問い合わせください。)
◆ページ数:100
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査資料では、炎症性腸疾患体外診断の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(アッセイ/バイオマーカー、アナライザー)、用途別市場規模(診断研究所、病院、研究機関)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・炎症性腸疾患体外診断の市場動向
・企業の競争状況、市場シェア
・炎症性腸疾患体外診断の種類別市場規模(アッセイ/バイオマーカー、アナライザー)
・炎症性腸疾患体外診断の用途別市場規模(診断研究所、病院、研究機関)
・炎症性腸疾患体外診断の北米市場規模2016-2027(アメリカ、カナダ)
・炎症性腸疾患体外診断の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・炎症性腸疾患体外診断のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・炎症性腸疾患体外診断の中南米市場規模2016-2027(メキシコ、ブラジル)
・炎症性腸疾患体外診断の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(DiaSorin S.p.A、F. Hoffmann-La Roche Ltd、Siemens Healthineers AG、Abbott、Quidel Corporation、American Laboratory Products Company (ALPCO)、Certest Biotec SL.、Biosystems S.A.)
・結論
【レポートの概要】

Inflammatory bowel disease is a group of medical conditions that causes chronic inflammation in the digestive tract. The inflammatory bowel disease is an umbrella term which comprises two principal disorders: ulcerative colitis and Crohn’s disease. Ulcerative colitis is a long-term medical indication that causes inflammation and sores in the inner lining of colon and rectum. Crohn’s disease is part of inflammatory bowel disease that causes inflammation to any part of gastrointestinal tract, right from mouth to small intestine and anus. The exact cause of inflammatory bowel diseases is not known; however, autoimmune disorders, genetic factors, and lifestyle changes are thought to cause the symptoms of inflammatory bowel diseases in an individual .Common symptoms of inflammatory bowel diseases include diarrhea, abdominal pain & cramps, constipation, rectal bleeding, weight loss, and fever. Inflammatory bowel diseases (IBD) affect men and women equally and is more commonly observed in developed countries in the West than developing and underdeveloped countries. There is no single test that can diagnose the inflammatory bowel disease. However, the laboratory tests primarily involve blood test, fecal test, and genetic test. The laboratory tests are performed in conjunction with other screening tests such as CT-Scan, colonoscopy, endoscopy, and MRI screening.

Market Analysis and Insights: Global In-vitro Inflammatory Bowel Disease Diagnostic Market
The global In-vitro Inflammatory Bowel Disease Diagnostic market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global In-vitro Inflammatory Bowel Disease Diagnostic market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global In-vitro Inflammatory Bowel Disease Diagnostic market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global In-vitro Inflammatory Bowel Disease Diagnostic market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global In-vitro Inflammatory Bowel Disease Diagnostic market.

Global In-vitro Inflammatory Bowel Disease Diagnostic Scope and Market Size
In-vitro Inflammatory Bowel Disease Diagnostic market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global In-vitro Inflammatory Bowel Disease Diagnostic market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Assays/Biomarker
Analyzers

Segment by Application
Diagnostic Laboratories
Hospitals
Research Institutes

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
DiaSorin S.p.A
F. Hoffmann-La Roche Ltd
Siemens Healthineers AG
Abbott
Quidel Corporation
American Laboratory Products Company (ALPCO)
Certest Biotec SL.
Biosystems S.A.

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global In-vitro Inflammatory Bowel Disease Diagnostic Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Assays/Biomarker
1.2.3 Analyzers
1.3 Market by Application
1.3.1 Global In-vitro Inflammatory Bowel Disease Diagnostic Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Diagnostic Laboratories
1.3.3 Hospitals
1.3.4 Research Institutes
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global In-vitro Inflammatory Bowel Disease Diagnostic Market Perspective (2016-2027)
2.2 In-vitro Inflammatory Bowel Disease Diagnostic Growth Trends by Regions
2.2.1 In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 In-vitro Inflammatory Bowel Disease Diagnostic Historic Market Share by Regions (2016-2021)
2.2.3 In-vitro Inflammatory Bowel Disease Diagnostic Forecasted Market Size by Regions (2022-2027)
2.3 In-vitro Inflammatory Bowel Disease Diagnostic Industry Dynamic
2.3.1 In-vitro Inflammatory Bowel Disease Diagnostic Market Trends
2.3.2 In-vitro Inflammatory Bowel Disease Diagnostic Market Drivers
2.3.3 In-vitro Inflammatory Bowel Disease Diagnostic Market Challenges
2.3.4 In-vitro Inflammatory Bowel Disease Diagnostic Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top In-vitro Inflammatory Bowel Disease Diagnostic Players by Revenue
3.1.1 Global Top In-vitro Inflammatory Bowel Disease Diagnostic Players by Revenue (2016-2021)
3.1.2 Global In-vitro Inflammatory Bowel Disease Diagnostic Revenue Market Share by Players (2016-2021)
3.2 Global In-vitro Inflammatory Bowel Disease Diagnostic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by In-vitro Inflammatory Bowel Disease Diagnostic Revenue
3.4 Global In-vitro Inflammatory Bowel Disease Diagnostic Market Concentration Ratio
3.4.1 Global In-vitro Inflammatory Bowel Disease Diagnostic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by In-vitro Inflammatory Bowel Disease Diagnostic Revenue in 2020
3.5 In-vitro Inflammatory Bowel Disease Diagnostic Key Players Head office and Area Served
3.6 Key Players In-vitro Inflammatory Bowel Disease Diagnostic Product Solution and Service
3.7 Date of Enter into In-vitro Inflammatory Bowel Disease Diagnostic Market
3.8 Mergers & Acquisitions, Expansion Plans

4 In-vitro Inflammatory Bowel Disease Diagnostic Breakdown Data by Type
4.1 Global In-vitro Inflammatory Bowel Disease Diagnostic Historic Market Size by Type (2016-2021)
4.2 Global In-vitro Inflammatory Bowel Disease Diagnostic Forecasted Market Size by Type (2022-2027)

5 In-vitro Inflammatory Bowel Disease Diagnostic Breakdown Data by Application
5.1 Global In-vitro Inflammatory Bowel Disease Diagnostic Historic Market Size by Application (2016-2021)
5.2 Global In-vitro Inflammatory Bowel Disease Diagnostic Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America In-vitro Inflammatory Bowel Disease Diagnostic Market Size (2016-2027)
6.2 North America In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Type
6.2.1 North America In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Type (2016-2021)
6.2.2 North America In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Type (2022-2027)
6.2.3 North America In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Type (2016-2027)
6.3 North America In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Application
6.3.1 North America In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Application (2016-2021)
6.3.2 North America In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Application (2022-2027)
6.3.3 North America In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Application (2016-2027)
6.4 North America In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Country
6.4.1 North America In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Country (2016-2021)
6.4.2 North America In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe In-vitro Inflammatory Bowel Disease Diagnostic Market Size (2016-2027)
7.2 Europe In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Type
7.2.1 Europe In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Type (2016-2021)
7.2.2 Europe In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Type (2022-2027)
7.2.3 Europe In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Type (2016-2027)
7.3 Europe In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Application
7.3.1 Europe In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Application (2016-2021)
7.3.2 Europe In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Application (2022-2027)
7.3.3 Europe In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Application (2016-2027)
7.4 Europe In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Country
7.4.1 Europe In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Country (2016-2021)
7.4.2 Europe In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific In-vitro Inflammatory Bowel Disease Diagnostic Market Size (2016-2027)
8.2 Asia-Pacific In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Type
8.2.1 Asia-Pacific In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Type (2016-2021)
8.2.2 Asia-Pacific In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Type (2022-2027)
8.2.3 Asia-Pacific In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Type (2016-2027)
8.3 Asia-Pacific In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Application
8.3.1 Asia-Pacific In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Application (2016-2021)
8.3.2 Asia-Pacific In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Application (2022-2027)
8.3.3 Asia-Pacific In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Application (2016-2027)
8.4 Asia-Pacific In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Region
8.4.1 Asia-Pacific In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Region (2016-2021)
8.4.2 Asia-Pacific In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America In-vitro Inflammatory Bowel Disease Diagnostic Market Size (2016-2027)
9.2 Latin America In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Type
9.2.1 Latin America In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Type (2016-2021)
9.2.2 Latin America In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Type (2022-2027)
9.2.3 Latin America In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Type (2016-2027)
9.3 Latin America In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Application
9.3.1 Latin America In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Application (2016-2021)
9.3.2 Latin America In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Application (2022-2027)
9.3.3 Latin America In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Application (2016-2027)
9.4 Latin America In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Country
9.4.1 Latin America In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Country (2016-2021)
9.4.2 Latin America In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa In-vitro Inflammatory Bowel Disease Diagnostic Market Size (2016-2027)
10.2 Middle East & Africa In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Type
10.2.1 Middle East & Africa In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Type (2016-2021)
10.2.2 Middle East & Africa In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Type (2022-2027)
10.2.3 Middle East & Africa In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Type (2016-2027)
10.3 Middle East & Africa In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Application
10.3.1 Middle East & Africa In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Application (2016-2021)
10.3.2 Middle East & Africa In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Application (2022-2027)
10.3.3 Middle East & Africa In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Application (2016-2027)
10.4 Middle East & Africa In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Country
10.4.1 Middle East & Africa In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Country (2016-2021)
10.4.2 Middle East & Africa In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 DiaSorin S.p.A
11.1.1 DiaSorin S.p.A Company Details
11.1.2 DiaSorin S.p.A Business Overview
11.1.3 DiaSorin S.p.A In-vitro Inflammatory Bowel Disease Diagnostic Introduction
11.1.4 DiaSorin S.p.A Revenue in In-vitro Inflammatory Bowel Disease Diagnostic Business (2016-2021)
11.1.5 DiaSorin S.p.A Recent Development
11.2 F. Hoffmann-La Roche Ltd
11.2.1 F. Hoffmann-La Roche Ltd Company Details
11.2.2 F. Hoffmann-La Roche Ltd Business Overview
11.2.3 F. Hoffmann-La Roche Ltd In-vitro Inflammatory Bowel Disease Diagnostic Introduction
11.2.4 F. Hoffmann-La Roche Ltd Revenue in In-vitro Inflammatory Bowel Disease Diagnostic Business (2016-2021)
11.2.5 F. Hoffmann-La Roche Ltd Recent Development
11.3 Siemens Healthineers AG
11.3.1 Siemens Healthineers AG Company Details
11.3.2 Siemens Healthineers AG Business Overview
11.3.3 Siemens Healthineers AG In-vitro Inflammatory Bowel Disease Diagnostic Introduction
11.3.4 Siemens Healthineers AG Revenue in In-vitro Inflammatory Bowel Disease Diagnostic Business (2016-2021)
11.3.5 Siemens Healthineers AG Recent Development
11.4 Abbott
11.4.1 Abbott Company Details
11.4.2 Abbott Business Overview
11.4.3 Abbott In-vitro Inflammatory Bowel Disease Diagnostic Introduction
11.4.4 Abbott Revenue in In-vitro Inflammatory Bowel Disease Diagnostic Business (2016-2021)
11.4.5 Abbott Recent Development
11.5 Quidel Corporation
11.5.1 Quidel Corporation Company Details
11.5.2 Quidel Corporation Business Overview
11.5.3 Quidel Corporation In-vitro Inflammatory Bowel Disease Diagnostic Introduction
11.5.4 Quidel Corporation Revenue in In-vitro Inflammatory Bowel Disease Diagnostic Business (2016-2021)
11.5.5 Quidel Corporation Recent Development
11.6 American Laboratory Products Company (ALPCO)
11.6.1 American Laboratory Products Company (ALPCO) Company Details
11.6.2 American Laboratory Products Company (ALPCO) Business Overview
11.6.3 American Laboratory Products Company (ALPCO) In-vitro Inflammatory Bowel Disease Diagnostic Introduction
11.6.4 American Laboratory Products Company (ALPCO) Revenue in In-vitro Inflammatory Bowel Disease Diagnostic Business (2016-2021)
11.6.5 American Laboratory Products Company (ALPCO) Recent Development
11.7 Certest Biotec SL.
11.7.1 Certest Biotec SL. Company Details
11.7.2 Certest Biotec SL. Business Overview
11.7.3 Certest Biotec SL. In-vitro Inflammatory Bowel Disease Diagnostic Introduction
11.7.4 Certest Biotec SL. Revenue in In-vitro Inflammatory Bowel Disease Diagnostic Business (2016-2021)
11.7.5 Certest Biotec SL. Recent Development
11.8 Biosystems S.A.
11.8.1 Biosystems S.A. Company Details
11.8.2 Biosystems S.A. Business Overview
11.8.3 Biosystems S.A. In-vitro Inflammatory Bowel Disease Diagnostic Introduction
11.8.4 Biosystems S.A. Revenue in In-vitro Inflammatory Bowel Disease Diagnostic Business (2016-2021)
11.8.5 Biosystems S.A. Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

...

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 炎症性腸疾患体外診断の世界市場規模・現状・予測2021年-2027年(Global In-vitro Inflammatory Bowel Disease Diagnostic Market Size, Status and Forecast 2021-2027)]についてメールでお問い合わせはこちらでお願いします。